A drug for women tested mostly in men

Photo credit: skodonnell photos

Some scientists see a major flaw in a recent study of the effects of alcohol consumption on a drug intended only for women.

The study of interactions between alcohol and Addyi, the first drug to treat female sexual dysfunction, enrolled 23 men—and two women.

“There is no valid reason to ignore the well-established biological and behavioral differences between men and women when conducting biomedical research,” said Carolyn M. Mazure, Ph.D., director of Women’s Health Research at Yale. “Yet it continues to happen.”

Sprout Pharmaceuticals, which markets Addyi, said in a statement that the study was designed with FDA guidance. “More men than women agreed to enroll in this kind of study,” the statement said, adding that Sprout plans to conduct additional studies on the effects of alcohol in women.


Other Roundup


After a heart attack, a disparity in outcomes

After a heart attack, a disparity in outcomes

A study that analyzed data on more than 132,000 white heart attack patients and almost 9,000 black...

Read more...


Fresh vegetables and primary care

Fresh vegetables and primary care

It’s time to add gardening to the arsenal of clinical skills. A nutrition workshop that was...

Read more...


Green lawns and frogs’ sex

Green lawns and frogs’ sex

Neatly manicured suburban lawns and gardens are playing havoc with the frogs’ endocrine systems,...

Read more...

Download on the Apple App Store